Novel Co-Admin of CAR T Cells Achieves 99% Remission in Leukemia
In the largest study to date of CAR T-cell therapy for relapsed and refractory childhood B-cell acute lymphoblastic leukemia, a novel approach led to undetectable disease in nearly all patients.
Source: medscape.com